Error: Could not add to watchlist. X
+ Watchlist

BioCryst Pharmaceuticals Inc

BCRX:US
NASDAQ GS
6.12
USD
0.03
0.49%
As of 8:10 PM EDT 6/23/2017
Open
6.09
Day Range
5.85 - 6.14
Volume
907,971
Previous Close
6.09
52Wk Range
2.60 - 9.25
1 Yr Return
115.49%
Before it's here, it's on the Bloomberg Terminal.
Learn More
Open
6.09
Day Range
5.85 - 6.14
Volume
907,971
Previous Close
6.09
52Wk Range
2.60 - 9.25
1 Yr Return
115.49%
YTD Return
-3.32%
Current P/E Ratio (TTM)
-
Earnings per Share (USD) (TTM)
-0.62
Market Cap (m USD)
492.182
Shares Outstanding (m)
80.422
Price/Sales (TTM)
14.66
Dividend Indicated Gross Yield
-
Sector
Health Care
% Price Change
-0.09%
% Price Change
-0.13%

Related Videos

There are currently no related videos for this ticker. Please check back later.
Profile
BioCryst Pharmaceuticals, Inc. designs, optimizes, and develops small-molecule novel pharmaceuticals that block key enzymes involved in infectious diseases, inflammatory diseases, and cancer. The Company has late-stage compounds in development and continues to discover additional compounds and to progress them to meet the unmet medical needs of patients and physicians.
Address
4505 Emperor Blvd
Suite 200
Durham, NC 27703
United States
Phone
1-919-859-1302
  • Jon P Stonehouse
    President/CEO
  • Thomas R Staab II "Tom"
    Sr VP/CFO/Treasurer
  • Lynne Powell
    Senior VP/Chief Commercial Ofcr
  • William P Sheridan
    Senior VP/Chief Medical Ofcr
  • Yarlagadda S Babu
    Senior VP:Drug Discovery
Show More